MedPath

NSABP FOUNDATION, INC.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.foundation.nsabp.org

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2024-03-21
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
5351
Registration Number
NCT00003782
Locations
🇺🇸

Comprehensive Cancer Institute, Huntsville, Alabama, United States

🇺🇸

Providence Alaska Medical Center, Anchorage, Alaska, United States

🇺🇸

CCOP - Western Regional, Arizona, Phoenix, Arizona, United States

and more 154 locations

Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Drug: Placebo
First Posted Date
2003-01-27
Last Posted Date
2011-04-19
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
1598
Registration Number
NCT00016432
Locations
🇺🇸

Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States

🇺🇸

CCOP - Greater Phoenix, Phoenix, Arizona, United States

🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

and more 159 locations

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

Phase 2
Completed
Conditions
Breast Neoplasms
First Posted Date
2003-01-27
Last Posted Date
2007-12-18
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
33
Registration Number
NCT00052169
Locations
🇺🇸

NSABP Operations Center, Pittsburgh, Pennsylvania, United States

Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2021-04-29
Lead Sponsor
NSABP Foundation Inc
Target Recruit Count
2130
Registration Number
NCT00004067
Locations
🇺🇸

Comprehensive Cancer Institute, Huntsville, Alabama, United States

🇺🇸

Providence Alaska Medical Center, Anchorage, Alaska, United States

🇺🇸

CCOP - Western Regional, Arizona, Phoenix, Arizona, United States

and more 146 locations

Tamoxifen Study

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Hypertension
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-11-02
Lead Sponsor
NSABP Foundation Inc
Registration Number
NCT00000529
© Copyright 2025. All Rights Reserved by MedPath